KSR@ authors are typically scientific researchers and/or ideas developers just like our readers! so all of them are specialists in their field. We want our writers to share the tips and tricks they have researched and learned, and we will give you plenty of help along the way. If you have a research paper or idea to share, here is how to turn it into a KSR@ article.
Who is the product owner of the and what are its duties? The Product Owner is the liaison between the development team and the customer. Contrary to its dubious name,
Preface: If you are facing a problem or project, which constantly encounters various changes during the implementation, in other words, the end, the end is not clear, and seeing the
Abstract In this paper, we propose an AI-FML robotic agent for student learning behavior ontology construction which can be applied in English speaking and listening domain. The AI-FML robotic agent
Abstract In order to improve network performance, including reducing computation delay, transmission delay and bandwidth consumption, edge computing and caching technologies are introduced to the fifth-generation wireless network (5G). However,
Abstract In this paper, we propose an AI-FML agent for robotic game of Go and AIoT real-world co-learning applications. The fuzzy machine learning mechanisms are adopted in the proposed model,
Abstract In this paper, we present a stochastic computing-based AI system for mobile devices. As technology in AI advances, more complex computations are required. In the case of mobile devices,
Abstract The automatic identification system (AIS) reports vessels’ static and dynamic infonnation, which are essential for maritime traffic situation awareness. However, AIS transponders can be switched off to hide suspicious
Abstract Game AI competitions are important to foster research and development on Game AI and AI in general. These competitions supply different challenging problems that can be translated into other
Oxford-AstraZeneca COVID-19 vaccine results expected by Christmas University of Oxford scientists expect to report results from late-stage trials of the COVID-19 vaccine it is developing with AstraZeneca by late December.
PFIZER AND BIONTECH CONCLUDE PHASE 3 STUDY OF COVID-19 VACCINE CANDIDATE, MEETING ALL PRIMARY EFFICACY ENDPOINTS Wednesday, November 18, 2020 – 06:59am Primary efficacy analysis demonstrates BNT162b2 to be 95%
